HOPE Reddit Mentions | ChartExchange

This is one of my favorite companies, and one which has a potential pathway to a $1B+ MC (currently at $130M).
**For serious investors** looking to invest at a great share price/MC, I recommend you **read every word of today's short PR including the About sections (link below)**. This is a HUGE deal for NRx.
Another key point contained in the PR in addition to the **6 bullets** at the top of the PR:
* The use of NRX-101 in conjunction with TMS for people with Treatment Resistant Depression. a far larger population of patients, estimated at 8.9 million American adults with an estimated **$44 Billion** burden of illness.
[NRx Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depression | Wed, 09/30/2026 - 07:00](https://ir.nrxpharma.com/news-releases/news-release-details/nrx-defense-systems-nrx-company-nasdaqnrxp-awarded-11-million)
**For reference, below is my post from a month ago:**
[NRx Pharmaceuticals (NRXP) - Two September Catalysts Upon Us : r/biotech\_stocks](https://www.reddit.com/r/biotech_stocks/comments/1w4isey/nrx_pharmaceuticals_nrxp_two_september_catalysts/)
**September News**:
* **Catalyst 1: NRX-100 ANDA (generic**
* NRXP's Sep 15 PR stated the **new GDUFA date** was set by the FDA for **November 10**.
* The FDA was a total disappointment and shows internal confusion. First, they called out a required manufacturer attestation for the luer lock vial as required (read more in the above link) and labeled it as a Major Amendment to the ANDA -- only to change it later to a Minor Amendment. Then, rather than use the normal 60-day Type 1 CRL time frame to set the new GDUFA date (Oct 10), they used 90 days (Nov 10). Truly disheartening and wrong, in my opinion.
* **Catalyst 2: NRX-100 NDA Filing**
* Originally hinted at filing in Sep 2026 in a recent shareholder update call. Disappointing on the part of NRx not to have filed by today. I really hope NRx is not having to be super cautious and having to wait for the Nov 10 ANDA approval to ensure the manufacturer attestation was acceptable to the FDA (since the same attestation was to be made part of the NRX-100 NDA filing to avoid that issue preventing approval).
* Still waiting for the filing ... could be any day now.
* **This is only my speculation and my hope:** that the delay in filing may have to do with the CNPV being granted, which would mean a 30-60 day decision time frame once the NDA is accepted by the FDA. That would be a WOW! From the About NRx section at the bottom of the PR:
* NRx has filed an Abbreviated New Drug Application (ANDA), **and initiated a New Drug Application filing for NRX-100 with an application for the Commissioner's National Priority Voucher Program**
Bottom line, there are 3 paths to success plus NRx has their HOPE Therapeutics clinics (I believe to be currently at a count of 8 locations).

.dark-mode .RxvKzW{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .RxvKzW{ color: #333333; background-color: white; border: 2px solid #333333; }HOPEHope Bancorp, Inc.stock NASDAQ

HOPE
Hope Bancorp, Inc.
stock NASDAQ